Generics BulletinAppearing to leapfrog an anticipated launch by rival Celltrion, Fresenius Kabi has begun shipping its Conexxence (denosumab-bnht) and Bomyntra (denosumab-bnht) biosimilars to Amgen’s Prolia and Xgeva
ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Lilly Will Try Camurus’s FluidCrystal D
Generics BulletinThe latest meeting of the European Medicines Agency’s Committee for Medicinal Products for Human Use resulted in a raft of positive opinions for the off-patent industry. After eight denosumab nods in
Pink SheetFour drugs with an orphan designation – Aucatzyl (obecabtagene autoleucel), Blenrep (belantamab mafodotin), Ezmekly (mirdametinib) and Maapliv (amino acids) – are among the 10 new products on track fo